| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af92759c928daeb7f0daabbb0499f059 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 |
| filingDate |
2005-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7ce6bfbc2fecee9b8ce01d211dd9f25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bdc867c3e7eeb07e583a045d13b60fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43416de8b409cc199792b1d86c889c51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b341717238a51d9f810efdfe57e53475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e4f86281e7f4a92de107fd73024f4a |
| publicationDate |
2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006068454-A1 |
| titleOfInvention |
Method of inactivating blood coagulation factor and blood coagulation factor-inactivated sample |
| abstract |
A method of inactivating a blood coagulation factor is described. The method comprises a step of contacting a sample containing at least one of factors V and VIII with a compound having an iminodiacetate group, whereby at least one of factors V and VIII in the sample is changed into an inactivated form. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009008600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005069969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7264936-B2 |
| priorityDate |
2004-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |